Skip to main content
Log in

In vitro susceptibility ofHelicobacter pylori to nitecapone

  • Letters
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ: Attempt to fulfill Koch's postulates for pyloric campylobacter. Medical Journal of Australia 1985, 142: 436–443.

    PubMed  Google Scholar 

  2. Morris A, Nicholson G: Ingestion ofCampylobacter pyloridis causes gastritis and raised fasting gastric pH. American Journal of Gastroenterology 1987, 82: 192–199.

    PubMed  Google Scholar 

  3. Borody TJ, Cole P, Noonan S, Morgan A, Lenne J, Hyland L, Brandl S, Borody EG, George LL: Recurrence of duodenal ulcer andCampylobacter pylori infection after eradication. Medical Journal of Australia 1989, 151: 431–435.

    PubMed  Google Scholar 

  4. Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication ofHelicobacter pylori. Lancet 1990, 335: 1233–1235.

    Article  PubMed  Google Scholar 

  5. Rauws EAJ, Langenberg W, Bosma A, Dankert J, Tytgat GNJ: Lack of eradication ofHelicobacter pylori after omeprazole. Lancet 1991, 337: 1093.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rautelin, H., Renkonen, O.V. & Kosunen, T.U. In vitro susceptibility ofHelicobacter pylori to nitecapone. Eur. J. Clin. Microbiol. Infect. Dis. 11, 274–275 (1992). https://doi.org/10.1007/BF02098102

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02098102

Keywords

Navigation